 predictor morbid mortal neonat herp simplex viru infect nation institut allergi infecti diseas collabor antivir studi group background control trial acyclovir vidarabin treatment neonat herp simplex viru hsv infect signific differ treatment adjust mortal morbid henc entir cohort clinic characterist eventu outcom neonat method data center infant month age hsv infect outcom multivari analys variabl diseas categori extent involv entri trial infect eye mouth infect result conclus death infant local hsv infect mortal rate neonat dissemin infect percent enceph percent addit risk death neonat coma entri rel risk intravascular coagulopathi rel risk prematur rel risk babi dissemin diseas hsv pneumon mortal rel risk survivor morbid frequent infant enceph rel risk infect rel risk seizur rel risk infect hsv type rel risk hsv infect skin eye mouth presenc recurr vesicl risk neurolog impair recurr